Details of the Drug Formulations

General Information of Drug (ID: DMG2X3E)

Drug Name
Pyrantel Drug Info
Synonyms
PYRANTEL; Pyrequan; 15686-83-6; Strongid; Pirantele [DCIT]; Pyrantelum; Pirantel; Pyrantel [INN:BAN]; Pyrantelum [INN-Latin]; Pirantel [INN-Spanish]; UNII-4QIH0N49E7; HSDB 3252; EINECS 239-774-1; CHEBI:8654; 4QIH0N49E7; (E)-1-Methyl-2-(2-(thiophen-2-yl)vinyl)-1,4,5,6-tetrahydropyrimidine; E-1,4,5,6-Tetrahydro-1-methyl-2-(2-(2-thienyl)vinyl)pyrimidine; Pirantele; 1-methyl-2-[(E)-2-(2-thienyl)vinyl]-5,6-dihydro-4H-pyrimidine; Pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)vinyl)-, (E)-; Pin-X
Indication
Disease Entry ICD 11 Status REF
Worm infection 1F90.Z Approved [1]
Cross-matching ID
PubChem CID
708857
ChEBI ID
CHEBI:8654
CAS Number
15686-83-6
TTD ID
D03PTH
INTEDE ID
DR1371
ACDINA ID
D00569

Full List of Drug Formulations Containing This Drug

Pyrantel 180 mg tablet
Company Formulation ID FDA Description
ProMex F18283 Magnesium stearate; Anhydrous dibasic calcium phosphate; Croscarmellose sodium; Microcrystalline cellulose
------------------------------------------------------------------------------------

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015